Novartis returns to sales growth in Q2 as newer medicines offset generic pressure (NVS)
Researcher with pipette ©National Institutes of Health New therapies drive quarterly revenue increase Novartis AG (NYSE:NVS) reported higher…
Novartis delivered sales growth in Q2 and further advanced the pipeline; Full-year guidance reaffirmed
Novartis Pharma AG Ad hoc announcement pursuant to Art. 53 LR Second quarter Net sales grew +1% (cc1,…
Novartis delivered sales growth in Q2 and further advanced the pipeline; Full-year guidance reaffirmed
Novartis Pharma AG Ad hoc announcement pursuant to Art. 53 LR Second quarter Net sales grew +1% (cc1,…
Novartis Q1 Earnings Call Highlights
Novartis logo Key Points Novartis said its growth drivers were up 34%, led by Kisqali, Pluvicto, Leqvio and…
Strong Sales Growth and Strategic …
Group Sales Growth: 7% overall; 9% excluding COVID-19 impact. Core Operating Profit Growth: 14% increase. Core Operating Margin:…